Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.77
-0.58-9.13%
At close: Dec 12, 4:00 PM EST
$5.78
0.010.17%
Pre-Market: 4:09 AM EST
Comments
Loading...
Candel Therapeutics (CADL) Stock Price, Quote, News & History
CADLNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Candel Therapeutics (CADL) stock?
You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.
Who are Candel Therapeutics (CADL) competitors?
Other companies in Candel Therapeutics’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Galectin Therapeutics Inc (NASDAQ:GALT), Immuneering Corp (NASDAQ:IMRX), Larimar Therapeutics Inc (NASDAQ:LRMR) and PepGen Inc (NASDAQ:PEPG).
What is the forecast, or price target, for Candel Therapeutics (CADL) stock?
Candel Therapeutics has a consensus price target of $16.20.
What is the current price for Candel Therapeutics (CADL)?
The stock price for Candel Therapeutics (NASDAQ: CADL) is $5.78 last updated December 15, 2025 at 7:59 PM EST.
Does Candel Therapeutics (CADL) pay a dividend?
There are no upcoming dividends for Candel Therapeutics.
When is Candel Therapeutics (NASDAQ:CADL) reporting earnings?
Candel Therapeutics does not have any upcoming earnings scheduled.
Is Candel Therapeutics (CADL) going to split?
There is no upcoming split for Candel Therapeutics.
What sector and industry does Candel Therapeutics (CADL) operate in?
Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
